Dr Reddy’s Laboratories Ltd along with its subsidiaries announced its intent to appeal the decision made by the US District Court for the District of New Jersey, in a preliminary injunction hearing with respect to further sales and commercialization of Dr Reddy’s Buprenorphine and Naloxone Sublingual Film within the US.
The company disagrees with the court’s decision and will vigorously appeal it.
Dr Reddy’s Laboratories Ltd along with its subsidiaries announced its intent to appeal the decision made by the US District Court for the District of New Jersey, in a preliminary injunction hearing with respect to further sales and commercialization of Dr Reddy’s Buprenorphine and Naloxone Sublingual Film within the US.
The company disagrees with the court’s decision and will vigorously appeal it.
No comments:
Post a Comment